{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:54Z","timestamp":1793865834198,"version":"4.6.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence, profile and predictors of infections in an Indian cohort with idiopathic inflammatory myopathies (IIM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed the records of a retrospective cohort with IIM enrolled from consecutive patients being followed up in the clinic, and these constituted the observation cohort. A newly diagnosed inception cohort with IIM were followed prospectively as the validation cohort for confirmation of observations and comparison with the observation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 68 patients in the observation cohort (average age 33.4\u2009years, female:male 4.2:1), 37 (54.4%) experienced 54 infections between them; of these 54 infections, 21 (38.8%) were major and recurrent infections and they occurred in 11 patients (16.17%) over 3.08\u2009years. Tuberculosis was the most common infection (12, 22.2%), with a predominance of extrapulmonary forms. Serum protein [odds ratio (OR) 0.44], platelets (0.44) at disease onset and daily steroid dose (1.04) predicted major infections on multivariate analysis. A higher daily dose of steroids at first infection correlated with number of recurrent infections. The infection-free 1-year survival was 73.8%.<\/jats:p>\n                    <jats:p>Of the 70 patients in the validation cohort (average age 35.7\u2009years, female:male 3.7:1), 3 had myositis attributed to an infection. A similar proportion of the cohort experienced infections (22, 33.3%) with similar number of major (10, 45.4%) and recurrent (4, 18%) infections being recorded. The most common infection was community-acquired pneumonia, followed by tuberculosis, with serum albumin (OR 0.25) at disease onset being the only predictor. The one-year infection-free survival rate was 64.7%. Those who had a major infection had increased mortality at 1\u2009year, with a survival rate of 60%, compared with 89.09% in those without.<\/jats:p>\n                    <jats:p>In both cohorts, a daily prednisone dose &amp;gt;6.25\u2009mg predisposed to major infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Major and recurrent infections are common in Indian IIM patients and confer higher risk for future infections and lower survival. Respiratory and atypical bacterial infections such as tuberculosis occur throughout the disease course.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab015","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T13:59:04Z","timestamp":1610114344000},"page":"4315-4326","source":"Crossref","is-referenced-by-count":15,"title":["High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-0178","authenticated-orcid":false,"given":"Rudrarpan","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9134-0999","authenticated-orcid":false,"given":"Pankti","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"2021090119443227500_keab015-B1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005792-200303000-00002","article-title":"Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy","volume":"82","author":"Viguier","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2021090119443227500_keab015-B2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021090119443227500_keab015-B3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10067-009-1181-4","article-title":"Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up","volume":"28","author":"Ng","year":"2009","journal-title":"Clin Rheumatol"},{"key":"2021090119443227500_keab015-B4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2152\/jmi.54.295","article-title":"Comparison of clinical course of polymyositis and dermatomyositis: a follow-up study in Tokushima University Hospital","volume":"54","author":"Tani","year":"2007","journal-title":"J Med Invest"},{"key":"2021090119443227500_keab015-B5","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/rheumatology\/keq279","article-title":"Infections in polymyositis and dermatomyositis: analysis of 192 cases","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology"},{"key":"2021090119443227500_keab015-B6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/annrheumdis-2020-eular.301","article-title":"Ab0581 high prevalence of tuberculosis in adults and children with IIM as compared with SLE: retrospective data review from a large cohort at a tertiary care center in India","volume":"79(Suppl 1","author":"Gupta","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021090119443227500_keab015-B7","article-title":"Infections are leading cause of in-hospital mortality in Indian patients with inflammatory myopathy","author":"Muhammed","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"2021090119443227500_keab015-B8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2020-eular.5979","article-title":"Fri0252 high early mortality in idiopathic inflammatory myopathies: results from inception cohort at a tertiary care center in Northern India","volume":"79(Suppl 1","author":"Mehta","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021090119443227500_keab015-B9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/1756-185X.13257","article-title":"Prevalence and predictors of asymptomatic vertebral fractures in inflammatory myositis","volume":"21","author":"Gupta","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2021090119443227500_keab015-B10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021090119443227500_keab015-B11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0961203319829817","article-title":"Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis","volume":"28","author":"Thong","year":"2019","journal-title":"Lupus"},{"key":"2021090119443227500_keab015-B12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/injr.injr_40_19","article-title":"Meeting report: myoIN \u2013 Pan-India collaborative network for myositis research","volume":"14","author":"Gupta","year":"2019","journal-title":"Indian J Rheumatol"},{"key":"2021090119443227500_keab015-B13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/injr.injr_95_20","article-title":"Development of the MyoCite biobank: cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis","volume":"15","author":"Naveen","year":"2020","journal-title":"Indian J Rheumatol"},{"key":"2021090119443227500_keab015-B14","article-title":"Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies","author":"Mehta","year":"2020","journal-title":"Indian J Rheumatol"},{"key":"2021090119443227500_keab015-B15","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"2021090119443227500_keab015-B16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021090119443227500_keab015-B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2021090119443227500_keab015-B18","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/art.23963","article-title":"Reliability and validity of the myositis disease activity assessment tool","volume":"58","author":"Sultan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021090119443227500_keab015-B19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00365540902744741","article-title":"Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus","volume":"41","author":"Jeong","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"2021090119443227500_keab015-B20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","article-title":"Infectious complications in polymyositis and dermatomyositis: a series of 279 patients","volume":"41","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2021090119443227500_keab015-B21","year":"2019"},{"key":"2021090119443227500_keab015-B22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/pubmed\/fdv034","article-title":"Tuberculosis in South Asian communities in the UK: a systematic review of the literature","volume":"38","author":"Offer","year":"2016","journal-title":"J Public Health (Oxf)"},{"key":"2021090119443227500_keab015-B23","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1038\/srep16303","article-title":"The increased risk of active tuberculosis disease in patients with dermatomyositis \u2013 a nationwide retrospective cohort study","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"2021090119443227500_keab015-B24","first-page":"123","article-title":"Dermatomyositis with tuberculous fasciitis","volume":"14","author":"Yoshida","year":"2004","journal-title":"Eur J Dermatol"},{"key":"2021090119443227500_keab015-B25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mus.880170705","article-title":"Tuberculous infection of skeletal muscle in a case of dermatomyositis","volume":"17","author":"Davidson","year":"1994","journal-title":"Muscle Nerve"},{"key":"2021090119443227500_keab015-B26","first-page":"380","article-title":"Tuberculosis of skeletal muscle in a case of polymyositis","volume":"28","author":"Huang","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2021090119443227500_keab015-B27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-007-0799-3","article-title":"Tuberculous myofasciitis in dermatomyositis","volume":"27","author":"Liu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"2021090119443227500_keab015-B28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2334-4-63","article-title":"First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis","volume":"4","author":"Mukhopadhyay","year":"2004","journal-title":"BMC Infect Dis"},{"key":"2021090119443227500_keab015-B29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00365540410015222","article-title":"Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test","volume":"36","author":"Ravn","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"2021090119443227500_keab015-B30","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.2169\/internalmedicine.55.5548","article-title":"Tuberculous fasciitis in polymyositis: a rare case of extrapulmonary tuberculosis","volume":"55","author":"Nagayama","year":"2016","journal-title":"Intern Med Tokyo Jpn"},{"key":"2021090119443227500_keab015-B31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009742.2017.1340514","article-title":"Pleural tuberculosis under rituximab therapy for anti-synthetase syndrome","volume":"47","author":"Gazaix-Fontaine","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2021090119443227500_keab015-B32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4103\/0028-3886.79163","article-title":"Resistant dermatomyositis complicated by tubercular myositis and successfully treated with rituximab","volume":"59","author":"Jois","year":"2011","journal-title":"Neurol India"},{"key":"2021090119443227500_keab015-B33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2010.03.012","article-title":"Tuberculous cellulitis as a manifestation of miliary tuberculosis in a patient with malignancy-associated dermatomyositis","volume":"65","author":"Kim","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2021090119443227500_keab015-B34","doi-asserted-by":"crossref","first-page":"bcr0820114675","DOI":"10.1136\/bcr.08.2011.4675","article-title":"Dermatomyositis masquerading musculoskeletal tuberculosis","volume":"2011","author":"Rajalingham","year":"2011","journal-title":"BMJ Case Rep"},{"key":"2021090119443227500_keab015-B35","first-page":"331","article-title":"Extrapulmonary tuberculosis infection in Mexican patients with idiopathic inflammatory myopathies","volume":"21","author":"V\u00e1zquez-del Mercado","year":"2015","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2021090119443227500_keab015-B36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/1756-185X.12053","article-title":"Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?","volume":"16","author":"Prasad","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"2021090119443227500_keab015-B37","first-page":"289","article-title":"Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series","volume":"17","author":"Hern\u00e1ndez-Cruz","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"2021090119443227500_keab015-B38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.61.3.251","article-title":"Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment","volume":"61","author":"Gaitonde","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2021090119443227500_keab015-B39","first-page":"3579","article-title":"[Preventive therapy for iatrogenic active tuberculosis in systemic lupus erythematosus patients]","volume":"94","author":"Ma","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2021090119443227500_keab015-B40","doi-asserted-by":"crossref","first-page":"e130540","DOI":"10.1172\/jci.insight.130540","article-title":"BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA+ and IGRA\u2013 Indian adults","volume":"4","author":"Rakshit","year":"2019","journal-title":"JCI Insight"},{"key":"2021090119443227500_keab015-B41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/1756-185X.13255","article-title":"Opportunistic infections in patients with idiopathic inflammatory myopathies","volume":"21","author":"Redondo-Benito","year":"2018","journal-title":"Int J Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab015\/36243110\/keab015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4315\/40215155\/keab015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4315\/40215155\/keab015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:45:46Z","timestamp":1630511146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/9\/4315\/6119387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,1,26]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab015","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,1,26]]}}}